Head-to-head · WeighScore
MultiMedRx vs Trimi
By GLP-1 ScorecardUpdated
Score comparison
Trimi has the higher recorded score — 86.4/100 to 57.6/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trimi combines compounded injections and care in monthly or prepaid plans; the annual discount is substantial, but prescription-issued refund limits deserve equal attention.
Before you choose
MultiMedRx does not publish a semaglutide price, so its MultiMedRx review sets out what it does disclose, while the Trimi review explains the conditions attached to Trimi's figure. The semaglutide cost page compares published rates across the field. Ask MultiMedRx for a written total before treating either one as the cheaper choice.
If neither one fits, MultiMedRx vs Vitara RX and MyFastRx vs Trimi compare each of them with another graded program, and the list of alternatives to MultiMedRx ranks the programs closest to MultiMedRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MultiMedRx | Trimi |
|---|---|---|
| WeighScore | 57.6/100 | 86.4/100 |
| Grade | C | B |
| Site position | #426 | #8 |
| Semaglutide | Not disclosed | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | Not disclosed | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Separates introductory and regular figures on the online cards.
- Describes evaluation and shipping in the advertised online package.
What to consider
- The public pages leave the selected debit, applicable care fee and renewal schedule unconfirmed.
- The published refund policy excludes sale items.
Site position #8 · B
Strengths
- Separate semaglutide and tirzepatide plans include prescribed medication and care
- Monthly, quarterly, six-month and annual charges published
- BelieveRx pharmacy and Arora Health care network publicly named; individual assignment and licenses still need confirmation
- Supplies and shipping included under the published offer
What to consider
- Compounded injections only; no current branded or oral route
- Monthly and quarterly plans renew automatically; six-month and annual continuation needs a new confirmed purchase
- Ordinary orders become nonrefundable once the prescription is issued, even before shipping
- A named pharmacy partner does not independently verify the pharmacy assigned to your order
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.